Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split
NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq:…
New site in Lommel, Belgium: Aqua free successfully completes set-up phase with ISO 9001 certification
Lommel / Hamburg, 01/15/2026 – Aqua free, a leading provider of innovative drinking-water…
Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa net sales recorded by Orion has potential to exceed EUR 1 billion in the future
January 14, 2026 01:30 ET | Source: Orion Oyj ORION CORPORATION STOCK EXCHANGE…
New data reinforces Ipsens commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
14 abstracts will be presented across a range of neurological conditions including…
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
— First randomized Phase III trial confirming the efficacy of MET inhibition…
Weaviate named a Leader and Outperformer by GigaOm and Emerging Leader by Gartner; Market Momentum Accelerates as Nonrelational DBMS Segment Grows 22.7%
Amsterdam City, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Weaviate, the AI database…
CORRECTION Visionary Holdings Inc.
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- In a release issued under…
Renderforest 1.0 Strengthens Global Creative Production With Unified AI System
Renderforest expands its platform with its own proprietary AI model, enabling text,…
Boehringer Ingelheim advances potential first-in-class IL-11 inhibitor to Phase II Clinical Research in Idiopathic Pulmonary Fibrosis
Not intended for US and UK audiences BI 765423 has been developed…
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
January 13, 2026 07:05 ET | Source: Sight Sciences, Inc. MENLO PARK,…
